Pete Meyers

Pete Meyers is the current Non-Executive Director & Deputy Chairman at Immutep. Pete has over 25 years of experience in the financial and healthcare industries.

Pete began their career as an Associate in Health Care Mergers and Acquisitions at Smith Barney Inc. From there, they moved to Dillon, Read & Co. as Vice President of Health Care Mergers and Acquisitions. In 1999, they joined Credit Suisse First Boston LLC as Managing Director of Health Care Investment Banking.

In 2005, Pete left Credit Suisse to join Deutsche Bank Securities Inc. as Managing Director/Co-Head of Global Health Care Investment Banking. During their time at Deutsche Bank, Pete was instrumental in growing the health care investment banking franchise.

In 2013, Pete left Deutsche Bank to join Tetralogic Pharmaceuticals as Chief Financial Officer and Treasurer. Pete served in this role for three years before joining Motif BioSciences Inc. as Chief Financial Officer in 2016.

In 2017, Pete joined Eagle Pharmaceuticals, Inc. as Chief Financial Officer. Pete served in this role for three years before returning to Immutep Limited in 2020.

Pete Meyers has a Bachelor of Science in Finance from Boston College and an MBA in Finance from Columbia Business School. Pete has also completed a bachelors degree from Chaminade High School.